AlphAIalphai — Financial news for AI agents
financialcontent.comAUG 64 min read$VITL

Vital Farms (NASDAQ:VITL) Surprises With Q2 CY2026 Sales, Full

Vital Farms (NASDAQ:VITL) reported Q2 CY2026 sales of $166 million, down 10.1% year over year, but slightly above Wall Street estimates. Full-year revenue guidance was $787.5 million at the midpoint, 1.7% above consensus. GAAP loss was $0.72 per share, 51.4% better than expected. The article also cites negative free cash flow and cash burn in Q2.

Original reporting
financialcontent.com
Published Aug 6, 2026, 1:15 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 6, 2026, 1:29 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About alphai AI DeskScoring methodologyReport an issue
Vital Farms (NASDAQ:VITL) Surprises With Q2 CY2026 Sales, Full — source image
Source · financialcontent.com
Decision brief

The 30-second read

$VITLNeutralMed
01

Why it matters

Investors must balance a revenue/guidance beat against deteriorating profitability and accelerating free cash flow burn, which can affect valuation and financing expectations.

02

Market read

A guidance beat may support the stock, but the cash burn and margin deterioration raise downside risk to longer-term profitability.

03

What to watch

The article notes EBITDA and gross margin missed expectations, but does not quantify segment drivers or cost actions that could explain the margin drop.

Relevance 7/10Novelty 6/10Timing: post-Q2 earnings release, same-day stock held flat at $12.36

Background

Vital Farms is an ethically positioned pasture-raised eggs and butter brand, reporting Q2 CY2026 results and full-year guidance.

Company-level read

Ticker impact

$VITLNeutralMedium confidence
Context

Vital Farms reported Q2 CY2026 revenue of $166M, down 10.1% YoY, while full-year revenue guidance of $787.5M beat estimates.

Expected impact

Near-term trading likely hinges on whether investors focus on guidance beat versus worsening cash burn and gross margin.

Evidence & confidence

The article provides specific revenue/guidance and cash-flow deterioration figures, but lacks a fresh catalyst beyond the earnings release itself.

Market effects

Sector

Signals pressure on smaller consumer staples with higher reinvestment needs, despite some demand for newer products.

Regional

None stated.

Global

None stated.

Counterpoint

What could challenge this read

The guidance beat and optimistic EBITDA outlook could outweigh the cash burn if investors believe working-capital and reinvestment intensity will normalize.

Key entities

  • company
    Vital Farms

    Reported Q2 CY2026 revenue decline, full-year revenue guidance beat, and worsening free cash flow/cash burn.

Read at source← All news

Related articles

AUG 6
$VITLMed

Why Vital Farms (VITL) Stock Is Up Today

Vital Farms (NASDAQ: VITL) shares rose about 3.9% after the company reported Q2 results. Revenue fell 10.1% year over year to $166 million, and the company swung to a net loss of $0.72 per share versus a $0.36 profit a year earlier. Gross margin dropped to 6.6% from 38.9%. Vital Farms reaffirmed full-year revenue guidance.

financialcontent.com4 min
JUL 23
$VITLMed

Vital Infrastructure Property Trust: Vital Infrastructure Property Trust Acquires East New York Health Hub in Brooklyn, New York

Vital Infrastructure Property Trust (TSX: VITL.UN) said it acquired the East New York Health Hub in Brooklyn, a 142,249 sq ft, seven-storey outpatient medical facility completed in 2019, for $126.7 million (US$89.9 million). The property is leased to AdvantageCare Physicians New York with about 11 years remaining and is expected to be immediately accretive to FFO per unit.

finanznachrichten.de2 min
AUG 8
$JANMedAI 8/10

JAN Q2 Earnings Call Highlights

Janus Living (NYSE:JAN) reported sequential same-store NOI margin down 40 bps, citing seasonality. Occupancy rose for independent living but fell for skilled nursing. The company acquired two communities for $105M, sold one for $23M, and completed $1B more acquisitions post-quarter. It raised 2026 FFO guidance to $0.95-$0.98 and same-store adjusted NOI growth to 13%-17%.

yahoo.com6 min
AUG 8
$JOBYMedAI 8/10

Joby Aviation Q2 Earnings Call Highlights

Joby Aviation (NYSE:JOBY) raised full-year revenue guidance to $115 million to $125 million from $105 million to $115 million. Q2 cash use was about $202 million and GAAP net loss was $245 million, including a $108 million non-cash warrant and earn-out fair value change. For 2H 2026, it expects $385 million to $415 million cash use. The company said aircraft availability is a key constraint on Blade routes and outlined manufacturing, infrastructure, and JV plans with Toyota.

yahoo.com6 min